Pamela E. Knapp

Pamela E. Knapp

Auto-generated profile, based on publicly available information

Pamela E. Knapp

Virginia Commonwealth University

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2008 in Glia
Verified
Journal Article
Closed access
PDF file
ABAnnadora J. Bruce‐Keller
Annadora J. Bruce‐Keller
JTJadwiga Turchan‐Cholewo
Jadwiga Turchan‐Cholewo
ESEric J. Smart
Eric J. Smart
TGTheresa Geurin
Theresa Geurin
ACAshok Chauhan
Ashok Chauhan
KHKurt F. Hauser
Kurt F. Hauser

30 December 2019 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
DADavid Alvarez-Carbonell
David Alvarez-Carbonell
FYFengchun Ye
Fengchun Ye
NRNirmala Ramanath
Nirmala Ramanath
YGYoelvis Garcia-Mesa
Yoelvis Garcia-Mesa
PKPamela E Knapp
Pamela E Knapp
JKJonathan Karn
Jonathan Karn
Despite effective antiretroviral therapy (ART), HIV-associated neurocognitive disorders (HAND) are found in nearly one-third of patients. Using a cellular co-culture system including neurons and human microglia infected with HIV (hμglia/HIV), we investigated the hypothesis that HIV-dependent neurological degeneration results from the periodic emergence of HIV from latency within microglial cells in response to neuronal damage or inflammatory signals. When a clonal hμglia/HIV population (HC69) expressing HIV, or HIV infected human primary and iPSC-derived microglial cells, were cultured for a short-term (24 h) with healthy neurons, HIV was silenced. The neuron-dependent induction of latency in HC69 cells was recapitulated using induced pluripotent stem cell (iPSC)-derived GABAergic cortical (iCort) and dopaminergic (iDopaNer), but not motor (iMotorNer), neurons. By contrast, damaged neurons induce HIV expression in latently infected microglial cells. After 48–72 h co-culture, low levels of HIV expression appear to damage neurons, which further enhances HIV expression. There was a marked reduction in intact dendrites staining for microtubule associated protein 2 (MAP2) in the neurons exposed to HIV-expressing microglial cells, indicating extensive dendritic pruning. To model neurotoxicity induced by methamphetamine (METH), we treated cells with nM levels of METH and suboptimal levels of poly (I:C), a TLR3 agonist that mimics the effects of the circulating bacterial rRNA found in HIV infected patients. This combination of agents potently induced HIV expression, with the METH effect mediated by the σ1 receptor (σ1R). In co-cultures of HC69 cells with iCort neurons, the combination of METH and poly(I:C) induced HIV expression and dendritic damage beyond levels seen using either agent alone, Thus, our results demonstrate that the cross-talk between healthy neurons and microglia modulates HIV expression, while HIV expression impairs this intrinsic molecular mechanism resulting in the excessive and uncontrolled stimulation of microglia-mediated neurotoxicity. Now that HIV patients are living longer due to improved anti-retroviral therapy, the prevalence of HIV-associated neurocognitive disorders (HAND) is rising. HAND is linked to chronic inflammation and microgliosis and is exacerbated by substances of abuse such as methamphetamine (METH). Using co-culture models of neurons and microglia, we demonstrate that healthy neurons can suppress HIV transcription in infected microglia over a short-term (24 h). By contrast, damaged neurons reactivate latent HIV expression. Thus, over a longer term (72 h), neurons lose the ability to suppress HIV expression, resulting in enhanced neural injury. This damaging cycle of latency reversal and neuronal degeneration can be exacerbated by METH and inflammation. Our results support the hypothesis that the dendritic simplification and neuronal injury associated with HAND results from viral reactivation induced by neuronal and microglial cross-talk and exogenous inflammatory stimuli.

18 November 2011 in Brain
Verified
Journal Article
Open access
PDF file
SZShiping Zou
Shiping Zou
SFSylvia Fitting
Sylvia Fitting
YHYun-Kyung Hahn
Yun-Kyung Hahn
SWSandra P. Welch
Sandra P. Welch
NENazira El-Hage
Nazira El-Hage
PKPamela E. Knapp
Pamela E. Knapp
Individuals infected with human immunodeficiency virus-1 who abuse opiates can have a higher incidence of virus-associated neuropathology. Human immunodeficiency virus does not infect neurons, but viral proteins such as transactivator of transcription and glycoprotein 120, originating from infected glia, are neurotoxic. Moreover, functional changes in glial cells that enhance inflammation and reduce trophic support are increasingly implicated in human immunodeficiency virus neuropathology. In previous studies, co-exposure with morphine enhanced transactivator of transcription neurotoxicity towards cultured striatal neurons. Since those cultures contained µ-opioid receptor-expressing astroglia and microglia, and since glia are the principal site of infection in the central nervous system, we hypothesized that morphine synergy might be glially mediated. A 60 hour, repeated measures paradigm and multiple co-culture models were used to investigate the cellular basis for opiate-enhanced human immunodeficiency virus neurotoxicity. Morphine co-exposure significantly enhanced transactivator of transcription-induced neuron death when glia were present. Synergistic effects of morphine on transactivator of transcription neurotoxicity were greatest with neuron–glia contact, but also occurred to a lesser extent with glial conditioned medium. Importantly, synergy was lost if glia, but not neurons, lacked µ-opioid receptors, indicating that opiate interactions with human immunodeficiency virus converge at the level of µ-opioid receptor-expressing glia. Morphine enhanced transactivator of transcription-induced inflammatory effectors released by glia, elevating reactive oxygen species, increasing 3-nitrotyrosine production by microglia, and reducing the ability of glia to buffer glutamate. But neuron survival was reduced even more with glial contact than with exposure to conditioned medium, suggesting that noxious elements associated with cell contact augment the toxicity due to soluble factors. Similar morphine–transactivator of transcription synergy was also observed in studies with the clade C sequence of HIV-1 transactivator of transcription, which did not cause neuron death unless morphine was present. Several paradoxical observations related to opiate effects were noted when µ-opioid receptors were specifically ablated from either glia or neurons. This suggests that µ-opioid receptor loss in isolated cell types can fundamentally distort cell-to-cell signalling, revealing opponent processes that may exist in individual cell types. Our findings show the critical role of glia in orchestrating neurotoxic interactions of morphine and transactivator of transcription, and support the emerging concept that combined exposure to opiates and human immunodeficiency virus drives enhanced pathology within the central nervous system.

19 December 2013 in Brain Structure and Function
Verified
Journal Article
Open access
PDF file
YHYun Kyung Hahn
Yun Kyung Hahn
EPElizabeth M. Podhaizer
Elizabeth M. Podhaizer
SFSean P. Farris
Sean P. Farris
MMMichael F. Miles
Michael F. Miles
KHKurt F. Hauser
Kurt F. Hauser
PKPamela E. Knapp
Pamela E. Knapp
HIV-associated damage to the central nervous system results in cognitive and motor deficits. Anti-retroviral therapies reduce the severity of symptoms, yet the proportion of patients affected has remained the same or increased. Although approximately half of HIV-infected patients worldwide are women, the question of whether biological sex influences outcomes of HIV infection has received little attention. We explored this question for both behavioral and cellular/morphologic endpoints, using a transgenic mouse that inducibly expresses HIV-1 Tat in the brain. After 3 months of HIV-1 Tat exposure, both sexes showed similar reduced open field ambulation. Male Tat+ mice also showed reduced forelimb grip strength and enhanced anxiety in a light–dark box assay. Tat+ males did not improve over 12 weeks of repeated rotarod testing, indicating a motor memory deficit. Male mice also had more cellular deficits in the striatum. Neither sex showed a change in volume or total neuron numbers. Both had equally reduced oligodendroglial populations and equivalent microglial increases. However, astrogliosis and microglial nitrosative stress were higher in males. Dendrites on medium spiny neurons in male Tat+ mice had fewer spines, and levels of excitatory and inhibitory pre- and post-synaptic proteins were disrupted. Our results predict sex as a determinant of HIV effects in brain. Increased behavioral deficits in males correlated with glial activation and synaptic damage, both of which are implicated in cognitive/motor impairments in patients. Tat produced by residually infected cells despite antiretroviral therapy may be an important determinant of the synaptodendritic instability and behavioral deficits accompanying chronic infection.

28 August 2008 in Glia
Verified
Journal Article
Open access
PDF file
KHKurt F. Hauser
Kurt F. Hauser
YHYun Kyung Hahn
Yun Kyung Hahn
VAValeriya V. Adjan
Valeriya V. Adjan
SZShiping Zou
Shiping Zou
SBShreya K. Buch
Shreya K. Buch
PKPamela E. Knapp
Pamela E. Knapp
Human immunodeficiency virus (HIV)‐infected individuals who abuse opiates show faster progression to AIDS, and enhanced incidence of HIV‐1 encephalitis. Most opiates with abuse liability are preferential agonists for μ‐opioid receptors (MORs), and MORs are expressed on both neurons and glia, including oligodendrocytes (OLs). Tat, gp120, and other viral toxins, cause neurotoxicityin vitroand/or when injected into brain, and co‐exposure to opiates can augment HIV‐1 protein‐induced insults to both glial and neuronal populations. We examined the effects of HIV‐1 Tat +/− opiate exposure on OL survival and differentiation.In vivostudies utilized transgenic mice expressing Tat1‐86regulated by an inducible glial fibrillary acidic protein promoter. Although MBP levels were unchanged on immunoblots, certain structural and apoptotic indices were abnormal. After only 2 days of Tat induction, OLs showed an upregulation of active caspase‐3 that was enhanced by morphine exposure. Tat also upregulated TUNEL staining, but only in the presence of morphine. Tat significantly reduced the length of processes in Golgi–Kopsch impregnated OLs. A greater proportion of cells exhibited diminished or aberrant cytoplasmic processes, especially when mice expressing Tat were co‐exposed to morphine. Collectively, our data show that OLsin situare extremely sensitive to effects of Tat +/− morphine, although it is not clear if immature OLs as well as differentiated OLs are targeted equally. Significant elevations in caspase‐3 activity and TUNEL labeling, and evidence of increased degeneration/regeneration of OLs exposed to Tat +/− morphine suggest that toxicity toward OLs may be accompanied by heightened OL turnover.

2 February 2010 in Journal of Proteome Research
Verified
Journal Article
Closed access
SFSylvia Fitting
Sylvia Fitting
SZShiping Zou
Shiping Zou
WCWen Chen
Wen Chen
PVPhu Vo
Phu Vo
KHKurt F. Hauser
Kurt F. Hauser
PKPamela E. Knapp
Pamela E. Knapp